2 results
Approved WMOCompleted
PART A and PART DTo assess the safety and tolerability of TAK-994 following multiple oral doses in subjects with narcolepsy with or without cataplexy (NT1 or NT2).PART B and PART C To assess the efficacy of TAK-994 on reducing excessive daytime…
Approved WMOCompleted
The objective of this study is to observe the anatomical and functional outcomes of ocriplasmin over a 6-month follow-up period.